References
- 1. Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y. Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter. 2004; 9:453-9.10.1111/j.1083-4389.2004.00260.x
- 2. Zheng PY, Hua J, Yeoh KG, Ho B. Association of peptic ulcer with increased expression of Lewis antigens but not cagA, iceA, and vacA in Helicobacter pylori isolates in an Asian population. Gut. 2000; 47:18-22.10.1136/gut.47.1.18
- 3. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996; 20:1161-81.10.1097/00000478-199610000-00001
- 4. McGee DJ, Mobley HL. Pathogenesis of Helicobacter pylori infection. Curr Opin Gastroenterol. 2000; 16: 24-31.10.1097/00001574-200001000-00005
- 5. Basso D, Navaglia F, Brigato L, Di Mario F, Rugge M, Plebani M. Helicobacter pylori non-cytotoxic genotype enhances mucosal gastrin and mast cell tryptase. J Clin Pathol. 1999; 52:210-4.10.1136/jcp.52.3.210
- 6. Munoz S, Hernandez-Pando R, Abraham SN, Enciso JA. Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J Immunol. 2003; 70:5590-6.10.4049/jimmunol.170.11.5590
- 7. Mysorekar VV, Dandekar CP, Prakash BS. Mast cells in Helicobacter pylori associated antral gastritis. Indian J Pathol Microbiol. 2003; 46:605-9.
- 8. Nakajima S, Bamba N, Hattori T. Histological aspects and role of mast cells in Helicobacter pylori-infected gastritis. Aliment Pharmacol Ther. 2004; 20 Suppl 1: 165-70.10.1111/j.1365-2036.2004.01974.x
- 9. Kayaselcuk F, Serin E, Gumurdulu Y, Bircan S, Tuncer I. Relationship between gastritis severity, Helicobacter pylori intensity and mast cell density in the antrum and corpus. Turk J Gastroenterol. 2002; 13:154-8.
- 10. Chen XY, Liu WZ, Shi Y, Zhang DZ, Xiao SD, Tytgat GN. Helicobacter pylori associated gastric diseases and lymphoid tissue hyperplasia in gastric antral mucosa. J Clin Pathol. 2002; 55:133-7.10.1136/jcp.55.2.133
- 11. Vivatvakin B, Theamboonlers A, Semakachorn N, Wongsawadi L. Prevalence of CagA and VacA genotype of Helicobacter pylori in Thai children. J Med Assoc Thai. 2004; 87:1327-31.
- 12. Velin D, Michetti P. Immunology of Helicobacter pylori infection. Digestion. 2006; 73:116-23.
- 13. Matsuhisa TM, Yamada NY, Kato SK, Matsukura NM. Helicobacter pylori infection, mucosal atrophy and intestinal metaplasia in Asian populations: a comparative study in age-, gender- and endoscopic diagnosis-matched subjects. Helicobacter. 2003; 8: 29-35.10.1046/j.1523-5378.2003.00121.x
- 14. Matsuo T, Ikura Y, Ohsawa M, Ogami M, Kayo S, Yoshimi N, et al. Mast cell chymase expression in Helicobacter pylori-associated gastritis. Histopathology. 2003; 43:538-49.10.1111/j.1365-2559.2003.01731.x
- 15. Saperas E. The role of mast cells in gastrointestinal inflammation. Gastroenterology. 1996; 110:1656-8.10.1053/gast.1996.v110.agast961656
- 16. Bodger K, Bromelow K, Wyatt JI, Heatley RV. Interleukin 10 in Helicobacter pylori associated gastritis: immunohistochemical localisation and in vitro effects on cytokine secretion. J Clin Pathol. 2001; 54:285-92.10.1136/jcp.54.4.285
- 17. Kempuraj D, Huang M, Kandere-Grzybowska K, Basu S, Boucher W, Letourneau R, et al. Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NFkappaB activation and intracellular calcium ion levels in normal human mast cells. Int Arch Allergy Immunol. 2003; 132:231-9.
- 18. Theoharides TC, Bielory L. Mast cells and mast cell mediators as targets of dietary supplements. Ann Allergy Asthma Immunol. 2004; 93:S24-34.10.1016/S1081-1206(10)61484-6
- 19. Temkin V, Kantor B, Weg V, Hartman ML, Levi-Schaffer F. Tryptase activates the mitogen-activated protein kinase/activator protein-1 pathway in human peripheral blood eosinophils, causing cytokine production and release. J Immunol. 2002; 169:2662-9.
- 20. Sasaki Y, Yoshimoto T, Maruyama H, Tegoshi T, Ohta N, Arizono N, Nakanishi K. IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity. J Exp Med. 2005; 202:607-16.
- 21. Erzin Y, Altun S, Dobrucali A, Aslan M, Erdamar S, Dirican A, et al. Analysis of serum antibody profile against H pylori VacA and CagA antigens in Turkish patients with duodenal ulcer. World J Gastroenterol. 2006; 12:6869-73.10.3748/wjg.v12.i42.6869
- 22. Liu Y, Ponsioen CI, Xiao SD, Tytgat GN, Ten Kate FJ. Geographic pathology of Helicobacter pylori gastritis. Helicobacter. 2005; 10:107-13.10.1111/j.1523-5378.2005.00304.x
- 23. Lin HJ, Perng CL, Lo WC, Wu CW, Tseng GY, Li AF, et al. Helicobacter pylori cagA, iceA and vacA genotypes in patients with gastric cancer in Taiwan. World J Gastroenterol. 2004; 10:2493-7. 10.3748/wjg.v10.i17.2493